Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucas Hendrik Overeem

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Expert Review of Neurotherapeutics|January 8, 2019
Erenumab for episodic migraine prophylaxisLucas Hendrik Overeem, Lars Neeb, Uwe Reuter
European Journal of Neurology|March 5, 2025
Comorbidities as risk factors for migraine onset: A systematic review and three-level meta-analysisMaria Terhart, Lucas Hendrik Overeem, Ja Bin Hong, et al.
CNS Drugs|July 17, 2021
Indirect Comparison of Topiramate and Monoclonal Antibodies Against CGRP or Its Receptor for the Prophylaxis of Episodic Migraine: A Systematic Review with Meta-AnalysisLucas Hendrik Overeem, Bianca Raffaelli, Jasper Mecklenburg, et al.
Frontiers in Neurology|June 18, 2020
Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational StudyBianca Raffaelli, Rea Kalantzis, Jasper Mecklenburg, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
A Scoping Review and Meta-Analysis of Anti-CGRP Monoclonal Antibodies: Predicting ResponseJa Bin Hong, Kristin Sophie Lange, Lucas Hendrik Overeem, et al.
Cephalalgia : an International Journal of Headache|September 28, 2021
Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort studyBianca Raffaelli, Maria Terhart, Lucas Hendrik Overeem, et al.
The Journal of Headache and Pain|January 1, 2022
Deterioration of headache impact and health-related quality of life in migraine patients after cessation of preventive treatment with CGRP(-receptor) antibodiesMaria Terhart, Jasper Mecklenburg, Lars Neeb, et al.
Journal of Medical Internet Research|November 12, 2021
Patients' and Health Care Workers' Perception of Migraine Images on the Internet: Cross-sectional Survey StudyBianca Raffaelli, Pia Kull, Jasper Mecklenburg, et al.
The Journal of Headache and Pain|June 23, 2021
Primary headaches during the COVID-19 lockdown in Germany: analysis of data from 2325 patients using an electronic headache diaryBianca Raffaelli, Jasper Mecklenburg, Simon Scholler, et al.
The Journal of Headache and Pain|March 30, 2022
Resumption of migraine preventive treatment with CGRP(-receptor) antibodies after a 3-month drug holiday: a real-world experienceBianca Raffaelli, Maria Terhart, Jasper Mecklenburg, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Expert Review of Neurotherapeutics|January 8, 2019
Erenumab for episodic migraine prophylaxisLucas Hendrik Overeem, Lars Neeb, Uwe Reuter
European Journal of Neurology|March 5, 2025
Comorbidities as risk factors for migraine onset: A systematic review and three-level meta-analysisMaria Terhart, Lucas Hendrik Overeem, Ja Bin Hong, et al.
CNS Drugs|July 17, 2021
Indirect Comparison of Topiramate and Monoclonal Antibodies Against CGRP or Its Receptor for the Prophylaxis of Episodic Migraine: A Systematic Review with Meta-AnalysisLucas Hendrik Overeem, Bianca Raffaelli, Jasper Mecklenburg, et al.
Frontiers in Neurology|June 18, 2020
Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational StudyBianca Raffaelli, Rea Kalantzis, Jasper Mecklenburg, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
A Scoping Review and Meta-Analysis of Anti-CGRP Monoclonal Antibodies: Predicting ResponseJa Bin Hong, Kristin Sophie Lange, Lucas Hendrik Overeem, et al.
Cephalalgia : an International Journal of Headache|September 28, 2021
Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort studyBianca Raffaelli, Maria Terhart, Lucas Hendrik Overeem, et al.
The Journal of Headache and Pain|January 1, 2022
Deterioration of headache impact and health-related quality of life in migraine patients after cessation of preventive treatment with CGRP(-receptor) antibodiesMaria Terhart, Jasper Mecklenburg, Lars Neeb, et al.
Journal of Medical Internet Research|November 12, 2021
Patients' and Health Care Workers' Perception of Migraine Images on the Internet: Cross-sectional Survey StudyBianca Raffaelli, Pia Kull, Jasper Mecklenburg, et al.
The Journal of Headache and Pain|June 23, 2021
Primary headaches during the COVID-19 lockdown in Germany: analysis of data from 2325 patients using an electronic headache diaryBianca Raffaelli, Jasper Mecklenburg, Simon Scholler, et al.
The Journal of Headache and Pain|March 30, 2022
Resumption of migraine preventive treatment with CGRP(-receptor) antibodies after a 3-month drug holiday: a real-world experienceBianca Raffaelli, Maria Terhart, Jasper Mecklenburg, et al.
Pageof 3